Quantitative expression of thrombopoietin receptor on leukaemia cells from patients with acute myeloid leukaemia and acute lymphoblastic leukaemia
Quantitative expression of thrombopoietin receptor on leukaemia cells from patients with acute myeloid leukaemia and acute lymphoblastic leukaemia
复制标题
急性髓细胞白血病和急性淋巴细胞白血病患者白血病细胞血小板生成素受体的定量表达
DOI:
10.1046/j.1365-2141.1998.00558.x
复制
发表时间:
1998
影响因子:
6.5
通讯作者:
R. Ohno
中科院分区:
文献类型:
--
作者:
A. Takeshita;K. Shinjo;M. Izumi;P. Ling;S. Nakamura;K. Naito;K. Ohnishi;R. Ohno
Using a non‐isotopic ligand binding assay, we quantitatively examined the amount of human thrombopoietin (TPO) receptor (TPO‐R) on leukaemia cells from 128 patients with acute myeloid leukaemia (AML) or acute lymphoblastic leukaemia (ALL). The TPO‐R was expressed in 53 (47%) of 114 AML cases, and an in vitro treatment with TPO led to proliferation (stimulation index >1.5) of leukaemia cells in 13 (20%) of 66 AML cases examined. The TPO levels had no relation to the FAB classification except for FAB‐M7 AML. All five FAB‐M7 cases expressed TPO‐R, and one of three FAB‐M7 examined showed in vitro proliferative response to TPO. Although there was no significant correlation (r = 0.3125) between the amount of TPO‐R and the proliferative response, all of the AML cases which showed the in vitro response had TPO‐R expression. There was no relationship between TPO‐R amount and CD phenotypes, or the amount of granulocyte‐colony stimulating factor (G‐CSF) receptor. TPO‐R was also expressed in two (14%) of 14 cases of ALL, and only these two cases had in vitro proliferative response to TPO. One had only lymphoid antigens, and the other had both lymphoid and myeloid antigens. Our results suggest that some leukaemia cells express functionally active TPO‐R.
影响因子:
2.2
作者:
BUTTKE, TM;MCCUBREY, JA;OWEN, TC
通讯作者:
OWEN, TC
影响因子:
20.3
作者:
Waller,EK;Huang,S;Terstappen,L
通讯作者:
Terstappen,L